HRG

HRG Full Name

histidine-rich glycoprotein

HRG Introduction

Histidine-rich glycoprotein (HRG) is a multifunctional plasma glycoprotein that plays crucial regulatory roles in various physiological processes, including homeostasis, immunity, and angiogenesis. First isolated from human serum by Heimburger and colleagues in 1972, HRG is predominantly synthesized in the liver and secreted into the bloodstream, with additional storage and release from platelet granules upon thrombin stimulation. Encoded by the HRG gene located on human chromosome 3q27.3, this protein has a molecular mass of approximately 75 kDa and consists of 507 amino acids in its mature form, following the cleavage of an 18-amino-acid leader sequence. Its widespread distribution in plasma and association with multiple biological pathways make HRG a key mediator of cellular and molecular interactions in the human body.

Figure 1. Crystal structure of the HRG N2 domain.(Source: Kassaar O, 2014)

Mechanisms of Action and Ligand Interactions
HRG exerts its functions through dynamic, context-dependent interactions mediated by its distinct domains. The histidine-rich region acts as a reversible sink for divalent cations and heparin, altering local ion availability and glycosaminoglycan activity. The N-terminal domains bind plasminogen and modulate its conversion to plasmin, influencing fibrinolysis and extracellular matrix remodeling. The C-terminal domain interacts with immunoglobulins, complement components, and cell-surface receptors such as FcγR. Under acidic or zinc-rich conditions (e.g., sites of inflammation or tumors), conformational shifts in HRG can expose cryptic binding sites, further tailoring its regulatory effects to the microenvironment.

Pathological Relevance in Disease
HRG exerts a wide range of physiological functions through its ability to bind numerous ligands, including heparin, heparan sulfate, plasminogen, thrombospondin, IgG, and divalent metal ions. A key role of HRG is the regulation of coagulation and fibrinolysis: it binds heparin and heparan sulfate in a zinc-dependent manner, modulates plasminogen activation, and balances procoagulant and anticoagulant pathways, potentially exhibiting prothrombotic effects under certain conditions. In the immune system, HRG regulates immune complex clearance by binding IgG subclasses with varying affinities, inhibiting the formation of insoluble immune complexes, and enhancing the phagocytosis of necrotic cells via heparan sulfate-dependent pathways. Additionally, HRG possesses antimicrobial activity against a range of pathogens, and modulates angiogenesis by blocking the antiangiogenic effects of thrombospondins and inhibiting vascular endothelial growth factor (VEGF) signaling.

Alternate Names for HRG

HRG; histidine-rich glycoprotein; histidine proline rich glycoprotein; HPRG; HRGP; thrombophilia due to elevated HRG; DKFZp779H1622; Histidine proline rich glycoprotein; Histidine rich glycoprotein; HPRG; HRGP; Thrombophilia due to elevated HRG; OTTHUMP00

• 1.Kassaar O, McMahon S A, Thompson R, et al. Crystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: implications for angiogenic regulation. Blood, The Journal of the American Society of Hematology, 2014, 123(12): 1948-1955.